Uncategorized

$INM Slated for Live Webcast at VirtualInvestorConferences.com

InMed Pharmaceuticals (NASDAQ: INM), a clinical-stage pharmaceutical company developing medications targeting diseases with high unmet medical need and leading the clinical development of cannabinol (“CBN”), will be featured at the upcoming VirtualInvestorConferences.com. InMed president and CEO is scheduled to present a real-time, interactive presentations during the two-day conference; InMed’s presentation will start at 1:30 p.m. ET on Sept. 8, 2021. During the presentation Adams will provide an overview of the company’s recent highlights as well as answer questions from potential investors in real time. Company highlights include the announcement that it has increased the yield of its proprietary IntegraSyn(TM) rare cannabinoid manufacturing approach to 5 g/L, further improving the overall economics in advance of commercial-scale production and that it has signed a nonbinding letter of intent to acquire BayMedica, a private company that specializes in the manufacture and commercialization of rare cannabinoids. In addition, as part of a phase 2 clinical trial, InMed has filed clinical trial applications in several countries. Virtual Investor Conferences (“VIC”) has developed a reputation for being a leading proprietary investor conference series; VIC events provide an interactive forum for publicly traded companies to meet and present directly with investors.

To register for the event, visit https://ibn.fm/0HHBZ

To view the full press release, visit https://ibn.fm/gYYIo

About InMed Pharmaceuticals Inc.

InMed is a clinical-stage pharmaceutical company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (“CBN”) and is developing IntegraSyn to produce pharmaceutical-grade cannabinoids. The company is dedicated to delivering new therapeutic alternatives to patients who may benefit from cannabinoid-based pharmaceutical drugs. For more information, please visit www.InMedPharma.com.

NOTE TO INVESTORS: The latest news and updates relating to INM are available in the company’s newsroom at http://ibn.fm/INM

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $INM Slated for Live Webcast at VirtualInvestorConferences.com

$IDEX Completes Commercial EV Ecosystem Reach through M&A Deal with Van Manufacturer VIA

  • Sustainability cultivator Ideanomics has reached an agreement with commercial EV vehicle manufacturer VIA Motors to acquire VIA in an all-stock transaction valued at $450 million
  • The VIA acquisition will solidify Ideanomics’ position as a made-in-America brand focused on building an end-to-end commercial EV ecosystem
  • Ideanomics has completed other M&A activity in recent months designed to establish sustainable solutions that reduce the harmful effects of pollutants on the earth’s climate, particularly involving wireless battery-charging technology for commercial fleets
  • The acquisition will help VIA to focus on completing the manufacturing process, with vehicles expected to roll out by 2023

New York-based Ideanomics (NASDAQ: IDEX) has been making a name for itself as a commercial electric vehicle (“EV”) industry innovator and on Aug. 30 the company announced an agreement it expects to be “transformative” in Ideanomics’ pursuit of providing end-to-end services for the commercial EV market.

Ideanomics’ planned 100 percent acquisition of Utah’s VIA Motors International, Inc. in an all-stock transaction is expected to grant Ideanomics a vehicle manufacturing element to complement its charging technologies for “an immediate leadership position in a rapidly growing market” and deliver another revenue path to growth and profitability, Ideanomics CEO Alf Poor said in a morning conference call before market opening Aug. 30.

“With Via we’re going to make the vehicles. Through our forced induction charging system with WAVE we’re going to be able to charge [them], through our relationship with [Germany’s Prettl Electronics Automotive] we’re going to be able to have outside battery storage to charge any type of fleets outside of a normal grid, and many other aspects, [to create a] complete ecosystem for Ideanomics,” Board Executive Chairman Shane McMahon said during the conference call (https://ibn.fm/3jcXs).

Via will make electric commercial vehicles including Class 2 through Class 5 cargo vans, trucks, and buses. The company’s CEO is Bob Purcell, who led the General Motors (“GM”) electric vehicle business in the 1990s and is known as “the father of the legendary GM EV1,” which was the first mass-produced EV.

“We were the car that started it all. … I was very proud of my group,” Purcell said in a Barron’s interview about the deal (https://ibn.fm/7lT7v). “We invented that technology … things like torque vector control for motors, battery management systems…none of that existed before the EV1.”

The agreement cements Ideanomics as a made-in-America brand and values VIA at $450 million, according to the news release announcing the agreement (https://ibn.fm/lS950). Poor told investors during the conference call that revenue forecasts for the acquisition will be announced in the near future as part of the proxy for shareholders.

Under the terms of the agreement, VIA shareholders will receive about 162 million shares of Ideanomics common stock after the application of certain purchase price adjustments, leaving VIA shareholders with ownership of about 25 percent of the combined company.

Ideanomics is separately advancing $50 million of financing to VIA in the form of a secured convertible note, according to the news release.

Production is planned for 2023, according to Barron’s.

“What they needed was a partner that could help them, allow them to focus on execution. Because execution is going to be the difference between who gets market share and who doesn’t,” Poor said.

For more information, visit the company’s website at www.Ideanomics.com.

NOTE TO INVESTORS: The latest news and updates relating to IDEX are available in the company’s newsroom at https://ibn.fm/IDEX

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $IDEX Completes Commercial EV Ecosystem Reach through M&A Deal with Van Manufacturer VIA

$FLGC Collaborates to Launch Cutting-Edge Global Cannabis Product Validation, Authentication Platform

Flora Growth Corp. (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, today announced its entry into agreements with TruTrace Technologies Inc. (CSE: TTT) (OTCQB: TTTSF) and Applied DNA Sciences Inc. (NASDAQ: APDN) to launch a complete and differentiated global cannabis product validation and authentication platform for consumers, distributors and government regulators. The initiative further demonstrates Flora’s commitment to operational excellence and transparency enabling immutable genome-to-sale supply chain validation for domestic and international trading partners and government regulators. “In today’s globalized market, supply chain provenance is becoming an increasingly important component for every major international CPG company. This is particularly true for the cannabis industry, where concerns over the sale and distribution of products from the illicit market persist for businesses,” said Jason Warnock, Flora Growth’s chief revenue officer. “Flora anticipates that the added assurance, efficiency and transparency brought by these technologies will optimize our value proposition to customers, differentiate us from peers and increase our sales opportunities.”

To view the full press release, visit https://ibn.fm/pFIsk

About Flora Growth Corp.

Flora is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. Visit www.FloraGrowth.ca or follow @floragrowthcorp on social for more information.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at http://ibn.fm/FLGC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $FLGC Collaborates to Launch Cutting-Edge Global Cannabis Product Validation, Authentication Platform

$CNSP Dog Study May Offer Insight into How Gliomas Impact the Immune System

recently conducted study has found that in comparison with low-grade gliomas, high-grade gliomas in canines contain more immune cells linked to suppressing immune response. The study adds to evidence suggesting that these tumors may recruit immune cells which assist with immunosuppression. Its findings may be useful in the development of future glioma treatments for both dogs and humans.

Gliomas are caused by support cells known as glial cells, which mutate and become cancerous. These cells are usually located throughout the spinal cord and brain. In canines, gliomas make up nearly 35% of all intracranial cancers and are the second most common tumor type in the central nervous system. The average rate of survival for dogs with gliomas who undergo radiation therapy ranges between 9 to 14 months, which is akin to the 14-month rate of survival for humans who undergo chemotherapy, radiation and surgery as part of their treatment for gliomas.

The main types of canine glioma include undefined glioma, astrocytoma and oligodendroglioma. Each type is classified as high- or low-grade based on the microscopic features present.

Immunotherapy treatments make use of an individual’s immune system to fight cancer. This treatment has shown promise in treating various types of cancer but hasn’t been successful in treating gliomas in people as this particular type of cancer suppresses the immune system to allow the tumor to grow. Scientists are working towards better understanding the interaction between the immune system and gliomas, with the objective being to improve therapeutic outcomes.

The study was conducted by a research team comprising of researchers from various institutions who examined more than 70 different gliomas that had been acquired from veterinary patients seen between 2006 and 2018 at the North Carolina State College of Veterinary Medicine. The team used computerized image and immune-histochemical tagging analysis to identify the numbers of every type of immune cell in each tumor. The immune cells included macrophages, regulatory T lymphocytes, T lymphocytes and B lymphocytes.

The researchers discovered that there were higher numbers of polarized macrophages and regulatory T lymphocytes in high grade tumors, in comparison with low-grade tumors.

The first author of the study, Gregory Krane, explained that in healthy people, regulatory T lymphocytes prevented autoimmune ailments. However, cancer sometimes recruited and activated these cells to prevent the immune system from fighting tumors. This is why regulatory T lypmhocytes were found to be higher in high-grade gliomas, in comparison with the numbers found in low-grade gliomas.

Krane hopes that the study will afford researchers more insights into how gliomas affect the immune system and in the long run, help in the development of better treatments for gliomas.

In the meantime, companies such as CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are working to develop superior remedies for the malignancies that impact the central nervous system as well as the brain.

NOTE TO INVESTORS: The latest news and updates relating to CNS Pharmaceuticals Inc. (NASDAQ: CNSP) are available in the company’s newsroom at https://ibn.fm/CNSP

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $CNSP Dog Study May Offer Insight into How Gliomas Impact the Immune System

$ANPC Symposium Highlights the Application of Biophysical Technology in Cancer Prevention and Treatment

  • AnPac Bio-Medical Science Co., Ltd. held its 2021 technical symposium, entitled “The Applications of Biophysical Technology in Cancer Prevention and Treatment” in Shanghai, China, on August 6, 2021
  • The symposium included attendees from various hospitals, universities, and Fortune 500 companies, including Thermo Fisher Scientific and AnPac Bio’s contract partner Roche Pharmaceuticals China
  • A recent report from Frost & Sullivan ranked AnPac Bio at #3 in the world and 1st  in China for the number of clinical samples analyzed amongst companies that offer next-generation early cancer screening and detection technology

AnPac Bio-Medical Science (NASDAQ: ANPC) recently held its 2021 technical symposium entitled “The Applications of Biophysical Technology in Cancer Prevention and Treatment.” The symposium was held in Shanghai, China, and was attended by life science Fortune 500 companies such as Thermo Fisher Scientific and Roche Pharmaceuticals.

Experts came together to discuss emerging cancer prevention and treatment theories and technologies, including the applications of biophysical technology to address these needs. Measurement of biophysical properties is the basis for Anpac Bio’s novel CDA technology. The Company’s CDA technology can rapidly detect 26 different types of cancers with a simple blood test.

Talking points of the symposium included the newly announced cooperation between AnPac Bio and Roche Pharmaceutical China, as well as Thermo Fisher Scientific’s latest developments in in-vitro diagnosis (“IVD”), and the clinical trials that have been held on AnPac Bio’s proprietary cancer differentiation analysis (“CDA”) technology, including recently unblinded and analyzed clinical data.

AnPac Bio is one of the first companies in the world to produce major theories and methods of multi-level, multi-parameter, and multi-cancer screening. The innovative technology has opened up a new field in early cancer screening that is based on a biophysical properties and has achieved significant results. In 2019, Frost & Sullivan ranked AnPac Bio third in the world and first in China among those companies in the region in terms of the number of clinical samples offering next-generation early cancer screening and detection.

With one of the largest sample libraries in the world and more than 220,000 samples tested, AnPac Bio is an innovative leader in the field. The company’s CDA technology has shown to be advantageous over traditional detection methods, allowing it to outperform in the early detection market. The company’s main goal for 2021 is to extend its major discoveries in the field of early cancer detection and also develop cancer treatment technologies.

“This technical symposium allowed people to better understand the most cutting-edge applications of biophysical technology in cancer prevention and treatment, and it also played an important role in promoting future research and development in cancer prevention and treatment,” Dr. Chris Yu, CEO and Chairman of AnPac Bio, said. “As a pioneer in the application of biophysics to cancer prevention and treatment, AnPac Bio continues to report new ideas and cutting-edge technology to the public, sharing the latest clinical study and trial results, and continuing to promote collaborations between industry, and academia.”

AnPac Bio has proven to be an early thought leader and developer of multi-cancer (also called pan-cancer) ideas and technology. The company’s patent applications and IP began in the early 2010’s, and by 2014 it had already announced a cancer screening product with the capability of screening 16 types of cancer earlier than anyone else in the industry.

AnPac Bio’s CDA technology combines the assessment of existing biomarkers with the biophysical properties and cellular proteins that signal the lead up to serious health conditions (including cancer). The technology can also be used to pinpoint the most likely location for cancer or predict where the risk will be high in the future. Having invented and championed the idea and method of “multi-level, multi-parameter” cancer screening, AnPac Bio’s contributions are now recognized and accepted by leading United States medical institutions and life science companies.

For more information, visit the company’s website at www.AnPacBio.com.

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at https://ibn.fm/ANPC

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $ANPC Symposium Highlights the Application of Biophysical Technology in Cancer Prevention and Treatment

$AMPG Highlights from First Six Months of 2021

September 8, 2021

AmpliTech Group Inc. (NASDAQ: AMPG) Highlights from First Six Months of 2021

  • AmpliTech posted $1,024,410 in total revenue for Q2’21, a 55% increase from the same period in 2020
  • It also announced having paid off $1 million in debt while securing $0.2 million in SBA loan forgiveness
  • The company also purchased $0.4 million worth of scientific equipment to enhance product development and testing
  • The first half of 2021 also saw AmpliTech complete its financial recapitalization and Nasdaq up-listing, thereby realizing a working capital of $29.8 million
  • All these achievements are positioning AmpliTech as the key infrastructure provider that supports 5G, satellite and other radio frequency communications infrastructure globally

On August 16, 2021, AmpliTech Group (NASDAQ: AMPG) announced its financial results for the second quarter of 2021 along with the first six months of the 2021 fiscal year (“Q2’21 and 6M’21”). Additionally, the company reviewed its growth outlook, its strides thus far, and some of the key milestones it achieved in the first half of 2021 (https://ibn.fm/7BCnP).

Most notably, the company posted a 55% Q2’21 revenue growth compared to Q2’20. Total revenue stood at $1,024,410, up from $660,669 during the same period in 2020. This also represented a 117% growth from Q1’21. AmpliTech also reported that its order backlog as of the date of the announcement was $2.45 million, all in contractual hardware and engineering services, anticipated for delivery over the next three to six months, as opposed to $2.4 million at the close of Q1’21 (https://ibn.fm/7BCnP).

The first six months of 2021 were significant for AmpliTech. For starters, the company completed its financial recapitalization and Nasdaq up-listing. This move allowed it to raise working capital of $29.8 million as of June 30 (https://ibn.fm/588HQ). This capital would go into product development, sales and marketing infrastructure investments while also offering the financial strength needed to engage with global customer prospects that were previously out of the company’s reach.

As of the close of the first half of the year, the company had paid $1 million in debt and secured $0.2 million in SBA loan forgiveness. AmpliTech also reported having purchased $0.4 million worth of scientific equipment that was meant to enhance product development and testing (https://ibn.fm/7BCnP). It also made a significant strategic investment in its secure LNA chip development joint venture partner SN2N.

AmpliTech is an enterprise that designs, develops and manufactures customer radio frequency (“RF”) components for the commercial, SATCOM, space and military markets. Its product line ranges from new offerings for the 5G/6G wireless ecosystem and infrastructure, along with quantum computing supporting the United States’ efforts to reach the coveted position of quantum supremacy. Since it was founded back in 2002, AmpliTech has remained committed to research and development (“R&D”), allowing it to remain at the forefront of emerging technologies globally.

So far, 2021 has been a great year for AmpliTech, and its management is confident that the trajectory will carry on for the remainder of the year. While making the announcement, Fawad Maqbool, the president, CTO and CEO of AmpliTech, noted:

“Our Q2 results reflect initial benefits of our significantly enhanced position and the gradual return of customer prospects to more normal planning and procurement activity for projects where our low noise amplifier solutions can deliver game-changing performance and ROI.”

He further added:

“Importantly, our financial recapitalization is allowing AmpliTech to engage for the first time with a range of very large customer prospects that were previously out of our reach (https://ibn.fm/7BCnP).”

AmpliTech has attributed the impressive 6M’21 performance on expanding sales force efforts and the growing demand for its low noise signal amplifiers. It hopes to further capitalize on this to achieve even faster and additional growth as time progresses.

“We are making strategic investments in product development, sales and marketing, and personnel and infrastructure to better position AmpliTech for hyper-growth opportunities we see across several markets, including satellite communications, the build out of true 5G infrastructure, quantum computing and space exploration,” noted Mr. Maqbool (https://ibn.fm/588HQ).

The company projects that there will be an unprecedented growth in the demand for wireless connectivity given the proliferation of smart devices, cloud computing, autonomous vehicles and content streaming in the next several years. Its investments so far position it to take advantage of this growth and assert its position as a key infrastructure provider to support 5G, satellite and other radio frequency communications infrastructure. So far, AmpliTech’s investments are bearing fruit, all while laying the foundation for the company’s further growth in the future.

For more information, visit the company’s website at www.AmpliTechInc.com.

NOTE TO INVESTORS: The latest news and updates relating to AMPG are available in the company’s newsroom at https://ibn.fm/AMPG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, September 8th, 2021 Uncategorized Comments Off on $AMPG Highlights from First Six Months of 2021

$TOBAF Operating in New Facilities, Ready to Produce Advanced Formulation

TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) facilities in Las Vegas are now operational and have provided additional operational space and production resources; TAAT is continuing to use its original facility as well. The operation announcement is right on schedule with the company’s plans and align with TAAT’s increase in domestic and international activity. The company has received new international purchase orders totaling more than C$1.6 million; the orders are for distribution throughout the United Kingdom, Ireland and Australia. TAAT has also expanded distribution in seven new states in the past two months. Samples of TAAT’s tobacco-free and nicotine-free alternative to traditional cigarettes, formulated with an advanced formulation of Beyond Tobacco(TM) using reconstituted material were recently sent to tobacco wholesalers in the United States, the United Kingdom, Ireland, Germany, Poland, France and Switzerland. The company reported that response to the product, TAAT(TM) was overwhelmingly positive with regard to the similarity of the product’s user experience compared to that of a tobacco cigarette. The reconstituted formulation of Beyond Tobacco is now ready for production. “With so many new international opportunities on the horizon, our facility expansion is a very important part of our growth strategy as we go into our second year of operations in which we expect TAAT to be launched in several new markets,” said TAAT CEO Setti Coscarella in the press release. “With an abundance of feedback about TAAT from smokers aged 21+ who have sampled the product since it first launched in Ohio in Q4 2020, our advanced formulation of the Beyond Tobacco base material has made the user experience even closer to that of smoking a tobacco cigarette. Samples of TAAT with this advanced formulation have been sent to tobacco wholesalers across Europe, and based on their sentiments, we are very confident that there will be even more TAAT placements in European markets in the near future.”

To view the full press release, visit https://ibn.fm/q7zOu

About TAAT Global Alternatives Inc.

TAAT Global Alternatives has developed TAAT, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco(TM), a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched first in the United States in Q4 2020 as the company seeks to position itself in the $814 billion global tobacco industry. For more information, please visit www.TAATGlobal.com.

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at http://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Tuesday, September 7th, 2021 Uncategorized Comments Off on $TOBAF Operating in New Facilities, Ready to Produce Advanced Formulation

$SRAX Highlights EdTech Market and Public Companies with Inaugural Sequire Conference

September 7, 2021

SRAX Inc. (NASDAQ: SRAX) Highlights EdTech Market and Public Companies with Inaugural Sequire Conference

  • SRAX offers a premier investor intelligence and communications platform branded Sequire for clients to track investors’ behavior and trends, and engage shareholders
  • SRAX is hosting its first Sequire EdTech Conference on September 13, 2021, which will include corporate presentations, keynote speakers and more
  • EdTech is a thriving marketplace forecast to grow from $85 billion in 2020 to $382 billion in 2028

Technology continues to be the hottest market around as evidenced by the NASDAQ Composite Index steadily setting new record highs as it charts a course toward 15,500. Within that market, education technology, or EdTech for short, is shining bright with SRAX (NASDAQ: SRAX) this month bringing together some of its stars in the first ever Sequire EdTech Conference, a one-day investor event featuring prominent virtual work and remote learning companies.

Sequire is SRAX’s premier investor intelligence and communications software-as-a-service (“SaaS”) platform that allows companies a means to track their investors’ behaviors and trends. Armed with this insight, public companies are in a better-informed position to engage current and potential investors across different marketing channels. The conference touches multiple value points for SRAX by featuring a burgeoning industry as a key opinion leader, showing off its platform to potential clients and investors, and putting a spotlight on public companies in the EdTech space.

Since COVID-19, there has been an existing trend for remote work and “non-traditional” education for at-home learning. Programs like Google Classroom and Zoom accelerated while schools were shuttered. With the resilient virus and its latest variant (delta) still prominent, schools across the country are once again shutting down, at least temporarily, as the nation tries to slow viral spread. Ahead of the new school year beginning, Dr. Richard Besser, a former official for the Centers for Disease Control and Prevention, told Today that he expects the fall season to again be challenging for schools (https://ibn.fm/8xBxt).

Against this backdrop, “there’s never been a more important time to invest in the companies making strides in remote workplaces and classrooms” reads the Sequire EdTech Conference website. The conference, which is being held from 11:30 AM ET – 5:30 PM ET on Monday, Sept. 13, 2021, will include presentations from over 10 publicly traded companies, one-on-one meetings, and panels with industry experts on the future of work and education.

According to Grand View Research, there are multiple catalysts that will undergird 19.9% compound annual growth for the global EdTech market from $84.49 billion in 2020 to $382.23 billion in 2028 (https://ibn.fm/e3B5f). The research firm sees, amongst other things, the integration of emerging artificial intelligence (“AI”), augmented (“AR”) and virtual reality (“VR”), and blockchain solutions into EdTech as growth drivers.

One speaker at the Sequire EdTech Conference is Dr. Ann Marie Sastry, president and CEO of Amesite, a premier sponsor of the event and an award-winning artificial intelligence software company focused on improving learning. Amesite’s AI-driven, online learning platform, has been named the winner of the 2020 Best and Brightest Companies to Work For in the Nation and 2020 National Best and Brightest in Wellness.

“EdTech has changed forever, and corporations have quickly changed the way they are training their employees. There is a great group of companies that are transforming this sector, many of which we have the pleasure of hosting at this event,” said Christopher Miglino, founder and CEO of SRAX, in a press release on the event.

For more information, please visit the SRAX website at www.SRAX.com.

NOTE TO INVESTORS: The latest news and updates relating to SRAX are available in the company’s newsroom at http://ibn.fm/SRAX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Tuesday, September 7th, 2021 Uncategorized Comments Off on $SRAX Highlights EdTech Market and Public Companies with Inaugural Sequire Conference

$RWBYF Announces Clear Path to Execute Business Strategy in Michigan

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a multistate cannabis operator and house of premium brands, today announced its receipt of adult use (recreational use) prequalification status pursuant to the licensing provisions of the Michigan Regulation and Taxation of Marihuana Act (“MRTMA”) and associated rules through a wholly owned operating subsidiary, RWB Michigan, LLC. According to the update, this Marijuana Regulatory Agency (“MRA”) approval represents the company’s authorization to move forward with its full operational strategy in the state of Michigan and complete the licensing process for its intended facilities. “Michigan has been one of the highest bars of entry to any market we’ve entered,” said RWB CEO and Chairman Brad Rogers. “The regulatory body has done it right, and all stakeholders should feel comfort with the level of scrutiny and governance they require to be compliant operators. This now provides a clear path for us to fully execute on our strategy of being the house of brands and being great channel partners to all of our distribution points as well as our own planned flagship retail locations.”

To view the full press release, visit https://ibn.fm/Rsi47

About Red White & Bloom Brands Inc.

The company is positioning itself to be one of the top three multistate cannabis operators active in the U.S. legal cannabis and hemp sector. RWB is predominantly focusing its investments on the major U.S. markets, including Michigan, Illinois, Massachusetts, Arizona and California with respect to cannabis, and the U.S. and internationally for hemp-based CBD products. For more information about the company, visit www.RedWhiteBloom.com.

NOTE TO INVESTORS: The latest news and updates relating to RWBYF are available in the company’s newsroom at http://ibn.fm/RWBYF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Tuesday, September 7th, 2021 Uncategorized Comments Off on $RWBYF Announces Clear Path to Execute Business Strategy in Michigan

$PLTXF Bolsters Expansion Plans, Growth Strategy with Launch of Redesigned Shopify-Powered Canadian Website

September 7, 2021

PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Bolsters Expansion Plans, Growth Strategy with Launch of Redesigned Shopify-Powered Canadian Website

As a multifaceted marketplace, PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) aims to redefine the plant-based space by providing consumers with all things plant-based across three main operational focal points — products, distribution and community.Firstly, PlantX offers over 5,000 plant-based products from established and new brands, with more added daily, as well as meal delivery across the United States and Canada. Secondly, it then distributes these products through a powerful, all-encompassing e-commerce ecosystem, along with flagship brick-and-mortar retail stores in high-traffic epicenters around the world. Notably, these stores aim to enhance the company’s e-commerce presence through interactive shopping.

Thirdly, PlantX is building a community by leveraging education and collaborations. The company regularly updates its website and YouTube channel (https://www.youtube.com/c/PlantX/videos) with informative resources on plant-based foods and vegan diets, packaged as blog articles, recipe videos, nutritional advice videos, or its video podcast series, currently in its second season. It even has a fitness vertical that builds bridges between people with fitness knowledge and those who need it.

With its operations firmly anchored on these three points, PlantX has set sights on growth. “The growth strategy for PlantX is surprisingly simple. The e-commerce platform is the main driver of growth. By offering the widest possible array of plant-based products, PlantX is positioned to be the online destination for all plant-based needs and desires,” says PlantX CEO Lorne Rapkin.

PlantX recently announced the launch of its redesigned Canadian website, powered by Shopify (https://ibn.fm/mvXl0). You can access the website at www.PlantX.ca.

“The company’s redesigned Canadian website was developed to better represent the company’s brand strategy, promote community engagement, improve customer satisfaction, and increase business reach,” explains the press release.

The website now features a refreshed and modern design, simplified navigation, and improved search tools and functionality to enhance the overall user experience and brand impact. At the same time, it still offers access to PlantX’s informative resources, namely its podcast series and blog articles.

Aiming to maximize the impact of the new platform, PlantX has also engaged UI/UX specialists to improve the website’s performance through better navigation speed and optimized conversion rates. The company intends to launch a new United States website on the Shopify platform later this year.

Through its e-commerce platform, the company can actualize its plans to expand globally, to Australia, Latin America, Europe, and Asia. By leveraging the Shopify embedded features, the company will be able to easily clone its current Canadian model and launch additional websites in other countries with a click of a button. When launching in a new country, the company will be able to simply duplicate the PlantX theme and website features on Shopify, and then use the cloned platform to add products relevant to the country of interest. The automation of the company’s e-commerce expansion activity will increase its business effectiveness and allow PlantX to focus its efforts on curating the best plant-based products and educational resources for its customers, therefore boosting community engagement and satisfaction.

“The decision to transition to Shopify as the main e-commerce platform to host the PlantX online presence is a strategic move that complements the company’s mission and expansion plans,” said PlantX Founder Sean Dollinger. “By leveraging the Shopify embedded features, PlantX will be able to replicate its current Canadian model and launch additional websites in other countries.”

PlantX is a one-stop shop for all things plant-based. It offers consumers an efficient e-commerce experience, interactive brick-and-mortar stores, and a home delivery system for products, recipes, meals, and more.

For more information, visit the company’s websites at www.PlantX.comwww.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Tuesday, September 7th, 2021 Uncategorized Comments Off on $PLTXF Bolsters Expansion Plans, Growth Strategy with Launch of Redesigned Shopify-Powered Canadian Website

$LEXX Releases Results of Human Clinical Study Showing Effective, Safe BP Reduction

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has announced that its human clinical study HYPER-H21-2, which features LEXX’s patented DehydraTECH(TM)-processed cannabidiol (“CBD”), demonstrates up to a 23% decrease in blood pressure when compared to placebo. According to the announcement, partial results are being released today with additional blood pressure subset analyses, sleep quality and all other data analyses will be reported when complete. Partial results indicate that at selected times during the 24-hour study, volunteers with mild to moderate hypertension averaged as much as a 20 mmHg (i.e., 23%) decrease in BP relative to placebo, with volunteers averaging a notable reduction of 7.0% (p<0.001) in systolic pressure. In addition, over the same period, volunteers averaged a significant reduction of 5.3% (p<0.001) in MAP and a significant reduction of 3.5% in diastolic pressure relative to an increase in diastolic pressure (-0.8 vs. +2.7; p<0.001) from baseline with DehydraTECH-CBD relative to placebo treatment. The company noted that these numbers are particularly remarkable because many drugs currently used to treat hypertension require several weeks of treatment and/or combination dosing before they produce comparable results. Moving forward, Lexaria will evaluate the results of its first two human clinical hypertension studies before its upcoming pulmonary human clinical hypertension study of 2021 begins. “Over the initial 24 hours, Lexaria’s 2021 hypertension program is now delivering blood pressure reduction results competitive with — and in some cases even superior to — established oral pharmaceutical hypertension drugs,” said Lexaria CEO Chris Bunka in the press release. “DehydraTECH-CBD demonstrated a sustained and augmented effect upon blood pressure attenuation throughout the day, indicating effectiveness of the repeat dosing treatment schedule used in this study.”

To view the full press release, visit https://ibn.fm/nYtb4

About Lexaria Bioscience Corp.

Lexaria Bioscience’s patented drug-delivery technology, DehydraTECH(TM), improves the way active pharmaceutical ingredients (“APIs”) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bioabsorption of cannabinoids and nicotine by 5 to 10 times, and, in some instances with cannabinoids by as much as 27 times, compared to standard industry formulations, as well as reduce time of onset from one to two hours to minutes, and mask unwanted tastes. The delivery systems are also being evaluated for orally administered, anti-viral drugs, nonsteroidal, anti-inflammatory drugs (NSAIDs) and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 21 patents granted and more than 50 patents pending worldwide. For more information about the company, please visit www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at http://ibn.fm/LEXX

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Tuesday, September 7th, 2021 Uncategorized Comments Off on $LEXX Releases Results of Human Clinical Study Showing Effective, Safe BP Reduction

$INM to Webcast Live at VirtualInvestorConferences.com September 8th

InMed Pharmaceuticals invites individual and institutional investors, as well as advisors and analysts, to attend real-time, interactive presentations on VirtualInvestorConferences.com

PR Newswire

VANCOUVER, BC Sept. 7, 2021 InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the manufacturing and development of rare cannabinoids, announced that Eric. A. Adams, President and CEO of InMed, will present live at VirtualInvestorConferences.com on September 8 , 2021.

(PRNewsfoto/VirtualInvestorConferences.com)

DATE: September 8th, 2021
TIME: 1:30 PM ET
LINK: https://bit.ly/3ylJi2m

This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates.

Learn more about the event at www.virtualinvestorconferences.com .

Recent Company Highlights:

  • InMed increased the yield of their proprietary IntegraSyn™ rare cannabinoid manufacturing approach to 5 g/L, further improving the overall economics in advance of commercial scale production.
  • InMed’s rare cannabinoid yield of 5 g/L significantly exceeds currently reported industry yields, further validating the IntegraSyn™ manufacturing approach as a commercially viable solution for large-scale, pharmaceutical-grade GMP production of rare cannabinoids.
  • InMed announced a non-binding letter of intent to acquire BayMedica, a private company based in Nevada and California that specializes in the manufacture and commercialization of rare cannabinoids.
  • InMed has filed clinical trial applications in several countries as part of a Phase 2 Clinical Trial to evaluate INM-755 (cannabinol) cream for the treatment of Epidermolysis Bullosa.

About InMed

InMed Pharmaceuticals is a clinical-stage company developing a pipeline of cannabinoid-based pharmaceutical drug candidates, initially focused on the therapeutic benefits of cannabinol (“CBN”) and is developing IntegraSyn™ to produce pharmaceutical-grade cannabinoids. The Company is dedicated to delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs. For more information, visit www.inmedpharma.com .

About Virtual Investor Conferences ®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.

A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group’s suite of investor relations services specifically designed for more efficient Investor Access.  Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

Cautionary Note Regarding Forward-Looking Information:

This news release contains “forward-looking information” and “forward-looking statements” (collectively, “forward-looking information”) within the meaning of applicable securities laws. Forward-looking information is based on management’s current expectations and beliefs and is subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. Forward-looking information in this news release includes statements about: presenting present live at the Virtual Investor Conferences on September 8, 2021 ; delivering new therapeutic alternatives to patients that may benefit from cannabinoid-based pharmaceutical drugs; advancing IntegraSyn ™ to commercial scale production; IntegraSyn ™ being a commercially viable solution for large-scale, pharmaceutical-grade GMP production of rare cannabinoids; and developing a pipeline of cannabinoid-based pharmaceutical drug candidates. All forward-looking information herein is qualified in its entirety by this cautionary statement, and InMed disclaims any obligation to revise or update any such forward-looking information or to publicly announce the result of any revisions to any of the forward-looking information contained herein to reflect future results, events or developments, except as required by law.

Tuesday, September 7th, 2021 Uncategorized Comments Off on $INM to Webcast Live at VirtualInvestorConferences.com September 8th

$IDEX Fleet Managers Lack Requisite Expertise to Make Decisions on EVs

The electrification of vehicular transport is all but inevitable, thanks to a variety of challenging but ultimately solvable factors such as high costs and poor charging infrastructure. However, most ordinary drivers are not willing to ditch their internal combustion engine (“ICE”) vehicles for electric vehicles (“EVs”). Fleets, on the other hand, can easily overcome these issues, and governments in several territories are encouraging companies and their fleet managers to electrify their fleets in a bid to reduce reliance on fossil fuels and clean up the air.

Municipalities and companies will have enough funds to purchase a couple of electric vehicles for a start, and since they usually have a central hub where all their vehicles return at the end of the day, they can install chargers in these locations and recharge their EV fleets overnight. Nevertheless, a new survey of 200 fleets, half of which already use electric vehicles, has found that that’s easier said than done. According to research from LeasePlan, a firm that specializes in automobile leasing and fleet management, one in three (29%) fleet managers believe they are not knowledgeable enough about electric vehicles to advise their drivers on EVs.

Furthermore, one in four (25%) fleet managers said that they would benefit a great deal from additional training on electric vehicles. When the fleet managers were asked the kind of training that would significantly add to their knowledge of EVs, 53% said they wanted to learn how to maximize battery range, and 53% were interested in carrying out vehicle checks. More than 50% wanted to learn more about EV charging, 40% were interested in the key differences between ICE vehicles and electric vehicles, while 30% wanted further training on health and safety. Even though fleet managers aren’t completely confident in their ability to lead the charge, the survey found that fleet drivers are becoming increasingly interested in EVs.

Four in five (80%) fleet managers revealed that their drivers had expressed interest in driving an electric vehicle within the past 12 months, and nine in ten (91%) said they had noticed their drivers increasingly talking about EVs among themselves. Lease Plan UK’s managing director Alfonso Martinez says the company’s research has uncovered just how little fleet teams, which are supposed to spearhead the transition to zero-emission vehicles, actually know about EVs. To ensure a smooth and efficient transition from ICE vehicles to EVs, fleets will need well-trained fleet managers at the helm.

But since a significant number of fleet managers believe they do not have the expertise they need to lead the transition, municipalities and fleets will have to invest in comprehensive training on EVs and provide managers with the right tools to handle the transition as efficiently as possible. This will ensure that the decision-makers have the data and research to meet increasingly strict emission standards, confident that their electric fleets are in the right hands.

It is becoming abundantly clear that attaining a transition to cleaner forms of vehicular travel will require a concerted effort involving a large group of entities, including for-profit companies such as Ideanomics Inc. (NASDAQ: IDEX), national and state governments, as well as other players in order to address the different bottlenecks along that journey.

NOTE TO INVESTORS: The latest news and updates relating to Ideanomics Inc. (NASDAQ: IDEX) are available in the company’s newsroom at https://ibn.fm/IDEX

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Tuesday, September 7th, 2021 Uncategorized Comments Off on $IDEX Fleet Managers Lack Requisite Expertise to Make Decisions on EVs

$FLGC Marks Milestone with Receipt of 2021 Commercial Export Quota of Psychoactive Cannabis Flower from Colombian Government

Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, has received its 2021 export quota from the Colombian Technical Quotas Group (“TQG”) of 7,900 kilograms of high-THC cannabis dried flower; the company anticipates using the dried flower for direct sale or to process into derivative products that will be exported. FLGC has already signed numerous agreements for the sale and distribution of the dried flower as well as derivative products into several international jurisdictions, including South Africa, Australia, Latin America and the European Union.

FLGC management stated that receiving the quota was a milestone for the company and noted that the new 2021 export quota allocation should be sufficient for the company to meet the international demand for its products for the remainder of 2021 and into 2022. According to the company, the highest prices in the industry are in the psychoactive cannabis market, with the average wholesale price of THC distillate oil projected to reach anywhere from $3,500 to $8,000 per kilogram. “We have been eagerly anticipating and preparing for this announcement by cloning thousands of plants, which we currently have in propagation waiting to be transferred into our fields,” said Flora Growth vice president of agriculture Javier Franco in the press release. “While awaiting this quota, we were focused on optimizing our cultivation strategy and demonstrating our industry-leading production costs of just $0.06 per gram, while continuing to build out our facilities and applying for third party certifications. While we prioritize planting the new high-THC cultivars, it’s also important to note we are actively harvesting our high-CBD crops, and anticipate that this harvest will create a robust pipeline of cannabis derivatives for Flora to use across its premium brands and products, as well as for export to multiple international markets.”

To view the full press release, visit https://ibn.fm/YXZFL

About Flora Growth Corp.

Flora Growth is a cannabis company that leverages natural, cost-effective cultivation practices to supply cannabis derivatives to its diverse business divisions of cosmetics, hemp textiles, and food and beverage. As the operator of one of the largest outdoor cultivation facilities, Flora strives to market a higher-quality premium product at below-market prices. By prioritizing natural ingredients and value-chain sustainability across its portfolio, Flora creates premium products that help consumers restore and thrive. For more information about the company, please visit www.FloraGrowth.ca.

NOTE TO INVESTORS: The latest news and updates relating to FLGC are available in the company’s newsroom at http://ibn.fm/FLGC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Tuesday, September 7th, 2021 Uncategorized Comments Off on $FLGC Marks Milestone with Receipt of 2021 Commercial Export Quota of Psychoactive Cannabis Flower from Colombian Government

$CYBN Not-for-Profit Organization Urges Health Canada to End Psilocybin Mushroom Prohibition

TheraPsil is urging Health Canada to end the five-decade prohibition against the possession of psilocybin mushrooms and the psychedelics these entheogenic fungi produce. The not-for-profit organization, which advocates for the therapeutic use of psilocybin, has spent months drawing up proposed legalization measures for these mushrooms based on the same regulations the federal government created for medical marijuana two decades ago.

Spencer Hawkswell, CEO of the British, Columbia-based organization stated that TheraPsil had sent a proposal to Jennifer Saxe, who is the director general of Health Canada. In his statement, Hawkswell revealed that the 165-page document focused on managing every aspect of licensing sellers and growers, packaging, security, quality control and, where those involved can be located and even, who can be involved. The document also included provisions for patients to register to cultivate their own mushrooms as well as a formula to help calculate how much a person would be allowed to cultivate. The formula is based on the mycelium amount.

Psilocybin has been illegal in Canada since 1975 and is prohibited under the Controlled Drug and Substances Act. Despite that status, studies have found that psilocybin has shown potential for treating addiction to substances such as cocaine, alcoholism or smoking. In addition, psilocybin has also shown promise in the treatment of death anxiety, post-traumatic stress disorder, major depressive disorder and even Alzheimer’s.

Last year, the Canadian health minister used her authority to grant legal exemptions to individuals with treatment-resistant depression and those with terminal illnesses. Thus far, more than 60 therapists and patients have been granted legal exemptions by Health Canada, all of which are valid for 12 months.

TheraPsil isn’t the only organization proposing regulations to make the use and possession of psilocybin and psilocybin mushrooms legal. The Canadian Psychedelic Association and the Multidisciplinary Association of Psychedelic Studies are also drawing up their own regulatory blueprints for consideration. In addition, Jim Doswell, a post-traumatic stress disorder patient who has applied for a ministerial exemption to use psilocybin as part of his therapy, provided TheraPsil with insights into the regulatory process as it drafted its proposal.

The director general of Health Canada and the department itself haven’t made any comments on these proceedings. At the moment, Health Canada’s official stance is to endorse clinical trials as a way to learn more about the potential benefits and risks of psilocybin. However, advocates note that a lot of scientific studies on the substance have been done and calling for regulation is justified.

This call to change the legality of the substance is given further credence by the fact that several Canada-based psychedelics companies, including Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), have made notable strides in developing therapeutic formulations from these substances.

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Tuesday, September 7th, 2021 Uncategorized Comments Off on $CYBN Not-for-Profit Organization Urges Health Canada to End Psilocybin Mushroom Prohibition

$ANPC Announces Ownership Increase in Subsidiary Holding

AnPac Bio-Medical Science (NASDAQ: ANPC) subsidiary AnPac Bio-Medical Science (Lishui) Co. Ltd. has increased its holding in AnPai (Shanghai) Healthcare Management Consultant Co. Ltd., one of its subsidiaries; the increase came after approval was granted by the company audit committee and board of directors. The company announced that in late August 2021 it finalized the share structure registration amendment with the local Administration Management Bureau. Before making the decision, company officials conducted rigorous due diligence that included obtaining financial and legal audits and appraisals by a qualified appraiser. AnPac Bio-Medical Science is a biotechnology company with operations in China and the United States. AnPai is a distributor of AnPac Bio’s cancer test products, posting solid numbers for the past three years with consistent growth in revenues and customer base. According to the announcement, AnPac Bio anticipates AnPai will provide future access to a wider range of customers, resulting in stronger customer channels and sales capability. “AnPac Bio is excited to have completed this important step,” said AnPac Bio CEO and chair Dr. Chris Yu in the press release. “We are able to successfully incorporate with AnPai’s wide diversity customers and high revenue growth through this transaction. In the future, we will achieve faster and greater progress and development in the diversity of customers and the professionalism of our services as well as projected sustainable revenue growth through our greater share ownership. We hope that customers will benefit from AnPac Bio’s CDA technology.”

To view the full press release, visit https://ibn.fm/GbIlC

About AnPac Bio-Medical Science Co.

AnPac Bio is a biotechnology company focused on early cancer screening and detection, with 142 issued patents as of March 31, 2021. With one CLIA- and CAP-registered clinical laboratory in the United States and two certified clinical laboratories in China, AnPac Bio performs a suite of cancer screening and detection tests, including Cancer Differentiation Analysis (“CDA”), biochemical, immunological and genomics tests. According to a Frost & Sullivan 2020 report, AnPac Bio ranked third worldwide among companies offering next-generation, early cancer screening and detection technologies in terms of the number of clinical samples for cancer screening and detection in 2019. The company has a significant cancer screening and detection database consisting of approximately 43,900 clinical samples as of March 31, 2021. AnPac Bio’s CDA technology platform has been shown in retrospective validation studies to be able to detect the risk of more than 20 different cancer types with high sensitivity and specificity. For more information about the company, visit www.AnPacBio.com

NOTE TO INVESTORS: The latest news and updates relating to ANPC are available in the company’s newsroom at http://ibn.fm/ANPC

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Tuesday, September 7th, 2021 Uncategorized Comments Off on $ANPC Announces Ownership Increase in Subsidiary Holding

$UUUU Reminds Holders about Warrants Expiration

Energy Fuels (NYSE American: UUUU) (TSX: EFR), the leading uranium producer in the United States, has issued a reminder. The company alerted holders of its outstanding common share purchase warrants that the warrants are scheduled to expire on Monday, Sept. 20, 2021, at 5 p.m. EDT. The company noted that the corresponding warrant indenture dated Sept. 20, 2016, between Energy Fuels, CST Trust Company and American Stock Transfer & Trust Company LLC is available on the U.S. Securities and Exchange Commission’s Electronic Document Gathering and Retrieval System. According to the announcement, any warrants not exercised prior to the expiration time and date will become void. The company recommended that, because warrants are “in the money,” holders take appropriate steps to protect their investment. The company also noted that the warrants trade on the NYSE American exchange under the symbol UUUU-WT as well as on the Toronto Stock Exchange under the symbol EFR.WT. The NYSE intends to suspend trading in the warrants after market close on Sept. 15, 2021, so that trades can be timely settled by the expiration date while the TSX will continue trading until market close on Sept. 20, 2021.

To view the full press release, visit https://ibn.fm/Hwpgj

About Energy Fuels Inc.

Energy Fuels is a leading U.S.-based uranium mining company, supplying U3O8 (“U3O8”) to major nuclear utilities. Energy Fuels also produces vanadium from certain of its projects, as market conditions warrant, and is ramping up to commercial-scale production of REE carbonate in 2021. Its corporate offices are in Lakewood, Colorado, near Denver, and all of its assets and employees are in the United States. Energy Fuels holds three of America’s key uranium production centers: the White Mesa Mill in Utah, the Nichols Ranch in-situ recovery (“ISR”) Project in Wyoming and the Alta Mesa ISR Project in Texas. The White Mesa Mill is the only conventional uranium mill operating in the U.S. today, has a licensed capacity of more than 8 million pounds of U3O8 per year, and has the ability to produce vanadium when market conditions warrant as well as REE carbonate from various uranium-bearing ores. The Nichols Ranch ISR Project is on standby and has a licensed capacity of 2 million pounds of U3O8 per year. The Alta Mesa ISR Project is also on standby and has a licensed capacity of 1.5 million pounds of U3O8 per year. In addition to the above production facilities, Energy Fuels also has one of the largest NI 43-101-compliant uranium resource portfolios in the United States and several uranium and uranium/vanadium mining projects on standby and in various stages of permitting and development. For more information, visit the company’s website at www.EnergyFuels.com.

NOTE TO INVESTORS: The latest news and updates relating to UUUU are available in the company’s newsroom at http://ibn.fm/UUUU

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, September 2nd, 2021 Uncategorized Comments Off on $UUUU Reminds Holders about Warrants Expiration

$TOBAF CEO Featured in Gamechangers LIVE Interview

TAAT(TM) Global Alternatives (CSE: TAAT) (OTCQX: TOBAF) (FRANKFURT: 2TP) CEO Setti Coscarella is the featured guest on a recent Gamechangers LIVE podcast episode. TAAT is a life sciences company working to give legal-aged smokers alternatives that allow them to still enjoy a smoking experience without the nicotine and tobacco. Hosted by executive coach and speaker Sergio Tigera, Gamechangers LIVE is a podcast series that focuses on leaders who are gamechangers in their fields; the podcast interviews these individuals and provides a platform for them to share their journeys, mindsets, struggles and successes as a way of inspiring and informing listeners. During his interview, Coscarella talked about his background and his unwavering commitment to professional success, noting that he’d earned an MBA with an emphasis on marketing and finance then started working in investment banking. His resulting career has followed many different paths — he even founded a men’s-focused trade show — ultimately bringing him to his current position. “I found myself working at Philip Morris,” said TAAT CEO Setti Coscarella during the podcast. “One of the categories that they were looking to develop was called ‘reduced risk products.’ So, basically, an ability to still deliver nicotine but in a way that isn’t as harmful as smoking cigarettes. I thought that that was an interesting pivot, because they were trying to put the well-being of their clientele more at the forefront. They were really looking at transforming the business as a whole while not completely forsaking their consumer base. It’s an interesting and challenging thing to do. . . . One thing that I noticed when I was there is that the vast majority of smokers have tried other products, but the one thing most smokers absolutely hate is the fact that they’re still addicted to this ritual. . . . Why can’t we give people something to smoke that isn’t addictive. . . . That way, we can give the freedom to choose back to them, no different from any other CPG product. . . . Our product, TAAT(TM), doesn’t have tobacco and it doesn’t have nicotine, but. . . it tastes like a cigarette, which is important.”

To view the full press release, visit https://ibn.fm/rOWAl

About TAAT Global Alternatives Inc.

TAAT Global Alternatives has developed TAAT, which is a tobacco-free and nicotine-free alternative to traditional cigarettes offered in Original, Smooth and Menthol varieties. TAAT’s base material is Beyond Tobacco(TM), a proprietary blend that undergoes a patent-pending refinement technique causing its scent and taste to resemble tobacco. Under executive leadership with Big Tobacco pedigree, TAAT was launched first in the United States in Q4 2020 as the company seeks to position itself in the $814 billion global tobacco industry. For more information, please visit www.TAATGlobal.com.

NOTE TO INVESTORS: The latest news and updates relating to TOBAF are available in the company’s newsroom at http://ibn.fm/TOBAF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, September 2nd, 2021 Uncategorized Comments Off on $TOBAF CEO Featured in Gamechangers LIVE Interview

$PLTXF Q1 Statement Notes Revenue Growth Amid M&A Activity

September 2, 2021
  • The growing plant-based consumer market one-stop shopping solution PlantX Life announced its most recent Q1 financials on Aug. 30
  • The financial statement notes revenue growth of $3.95 million YOY (Canadian) as part of PlantX’s drive to build a number of verticals to support its one-stop-shop mission since the company acquired PlantX Living in a reverse takeover in August 2020
  • PlantX Life also improved on the previous quarter’s 23 percent gross margin to achieve a gross margin of 28 percent
  • The company is expanding from its flagship store in Squamish, British Columbia to open similar stores in Southern California and Israel with a significant e-commerce operation seeking to educate and provide a wide variety of products for the plant-based community

Canadian e-commerce and plant-based community builder PlantX Life (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) is celebrating reports of its growing revenues and operational foothold following the announcement of its Q1 financial statement’s filing.

The Vancouver, British Columbia-based company is developing a one-stop shopping experience for the plant-based community, simultaneously working to educate consumers about the virtues of plant-based living and help develop a cohesive coterie of like-minded food enthusiasts.

PlantX Life’s interim unaudited condensed consolidated financial results for the three months ended June 30 note the company generated gross revenue of more than $4 million (Canadian), which was an increase of $3.95 million YOY (https://ibn.fm/vN7LU).

During the past year, the company has undergone a period of rapid vertical building as part of its mis sion to grow a model similar to e-commerce giant Amazon’s but devoted to plant-based consumer interests.

PlantX sells more than 5,000 products in line with its mission and plans to expand its offerings to include cosmetics, clothing, and its own water brand. While e-commerce is a significant part of its operations, the company maintains a flagship storefront in Squamish, British Columbia and is establishing additional physical stores in San Diego, California and Tel Aviv in the state of Israel to serve those nationalities (https://ibn.fm/bXyvs).

According to the financial statement, the company achieved a gross margin of 28 percent for the quarter, compared to 23 percent during the previous quarter. As of June 30, PlantX had working capital of nearly $15 million, inclusive of $13.5 million in cash.

“PlantX continues to invest its efforts and resources strategically to grow and meet the demand for our plant-based products,” founder Sean Dollinger stated. “It is encouraging to see the impact of our work. We are more committed than ever to continue building our business by executing on our mission and expansion goals.”

Those investments include the acquisition of PlantX Living Inc. in a reverse takeover completed Aug. 5, 2020; the acquisition of Bloombox Club Ltd. completed Nov. 6; the acquisition of Score Enterprises Ltd. completed Jan. 7 of this year; the acquisition of Little West LLC completed May 10; the acquisition of all of the issued and outstanding membership interests of MK Cuisine Global LLC’s Plant-Based Deli LLC completed on May 27; and the acquisition of certain assets of LIV Marketplace LLC completed June 25, according to the company management’s accompanying discussion and analysis found on its SEDAR profile (https://ibn.fm/wE4GG).

Bloombox is a service that hand-delivers locally grown plants and gardening supplies to consumers. Score Enterprises operated the Squamish restaurant location’s related operations that became the company’s flagship store. Little West LLC is a privately owned, California-based cold-pressed juice company. Deli LLC, also known as New Deli, is a sustainable and plant-based retail store in Venice Beach, Calif. LIV Marketplace, also part of the New Deli operation, is the San Diego, Calif., retail partner     responsible for the fulfillment of PlantX’s online product distribution within the United States.

The San Diego store will open in September, and PlantX announced July 28 that its XFood delivery service in Southern California will use a ghost kitchen in central Los Angeles as part of an operation modeled after its food delivery services in British Columbia.

For more information, visit the company’s websites at www.PlantX.comwww.PlantX.ca, and https://investor.plantx.com/ and view PlantX for Plant-Based Investors.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at https://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@InvestorWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, September 2nd, 2021 Uncategorized Comments Off on $PLTXF Q1 Statement Notes Revenue Growth Amid M&A Activity

$NEXCF Appoints Bradley Gittings as VP, Investor Relations

Nextech (CSE: NTAR) (NEO: NTAR) (OTCQB: NEXCF) (FSE: N29), a diversified leading provider of augmented reality (“AR”) experience technologies and services, today announced the appointment of Bradley Gittings as its new vice president of investor relations. He brings to the company over twenty years of experience in investments, capital markets and investor relations. Gittings’ experience includes the formation of IR programs for Hitachi Data Systems (“HDS”), as well as for Altiris Inc., which was acquired by Symantec Corp. for US$830 million in 2007. “Nextech’s growing suite of augmented reality solutions are attracting a lot of attention, not only from customers but also from investors and analysts,” said Evan Gappelberg, founder and CEO of Nextech. “Bradley’s experience and success in building IR programs that respond to investor and financial analyst expectations will enable us to communicate to both retail and institutional investors.”

To view the full press release, visit https://ibn.fm/JIrCD

About Nextech AR Solutions Corp.

Nextech develops and operates augmented reality (“AR”) platforms that transport three-dimensional (“3D”) product visualizations, human holograms and 360° portals to its audiences, altering e-commerce, digital advertising, hybrid virtual events (events held in a digital format blended with in-person attendance), as well as learning and training experiences. Nextech focuses on developing AR solutions; however, most of the company’s revenues are currently derived from three ecommerce platforms, VacuumCleanerMarket.com (“VCM”), InfinitePetLife.com (“IPL”) and TruLyfeSupplements.com (“TruLyfe”), as well as VCM and product sales of residential vacuums, supplies and parts, and small home appliances sold on Amazon. For more information about the company, visit www.NextechAR.com.

NOTE TO INVESTORS: The latest news and updates relating to NEXCF are available in the company’s newsroom at http://ibn.fm/NEXCF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, September 2nd, 2021 Uncategorized Comments Off on $NEXCF Appoints Bradley Gittings as VP, Investor Relations

$NETE EV Firms Opt for More Affordable Production Methods

More than a decade after California-based startup Tesla unveiled the Tesla Roadster and proved that road-worthy electric vehicles (“EVs”) were a viable mass-market option, Tesla is now the largest electric vehicle maker as well as the most valuable car company on the planet. It currently has a backlog of 400,000 Model 3 orders and a production rate of 1,000 cars per day, and the EV maker has produced more than 360,000 EVs since the Roadster first hit the roads.

However, Tesla’s journey to the helm of the nascent EV sector was fraught with complications, especially regarding scaling up production for the mass market. New entrants into the electric vehicle space are taking different roads to avoid these issues.

Some have cast their nets out and found investors willing to pour billions of dollars into their startups, ensuring they have more than enough financing to set up large factories and start producing thousands of electric vehicles without having to deal with a myriad of production delays. For instance, Michigan-based automaker Rivian claims to have raised a whopping $10.5 billion in capital from Ford Motor Company and Amazon to finance the production of electric SUVs, trucks and vans. And in July, EV startup Lucid Motors went public and collected $4.5 billion in funding, which will allow it to get its first EV, the luxurious Lucid Air, on the road.

Electric vehicle makers who haven’t been able to raise such extensive capital are now looking at innovative production methods that will reduce the cost of mass EV production to avoid the production delays that plagued Tesla’s initial foray into mass electric vehicle production. Traditionally, carmakers would build around 240,000 vehicles per year at a cost of $2 billion, but EV makers are now building smaller “microfactories” with fewer or less-expensive equipment that churn out fewer vehicles at a reduced cost. London-based Arrival has gone this route, using microfactories worth around $40–$50 million equipped with fewer expensive machinery to build electric vans and buses.

Arrival has developed lightweight, colored plastics, eliminating the need for special painting equipment, which can cost hundreds of millions of dollars. Additionally, its engineers have built molds for plastic vehicle parts for thousands of dollars rather than traditional metal equipment, which would have cost the company millions of dollars. Arrival is also looking to take advantage of reduced shipping costs and accessible labor by installing its microfactories close to major markets around the globe. After raising $660 million back in March via a public offering, Arrival is now building two plants in the United States, one to develop electric buses and another for vans.

Canoo, another American electric vehicle startup, will also build microfactories, and according to the firm’s leader Tony Aquila, it will build a larger microfactory to act as a hub for the smaller ones. Electric Last Mile Solutions will reassemble prefinished electric vans made in China at an Indiana-based General Motors plant, a move that will save the company hundreds of millions of dollars in equipment. In fact, other startups are cutting costs by doing production overseas, and most of them plan to localize production as profits grow.

The magnitude of creativity being brought into the EV space may not have reached its peak just yet given that many more companies, including Net Element (NASDAQ: NETE), are switching from other industries and joining the electric vehicle industry. Such changes often come with new twists in the way things are done.

NOTE TO INVESTORS: The latest news and updates relating to Net Element (NASDAQ: NETE) are available in the company’s newsroom at http://ibn.fm/NETE

About Green Car Stocks

Green Car Stocks (GCS) is a specialized communications platform with a focus on electric vehicles (EV), as well as other emerging market opportunities in the green sector. The company provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, GCS is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, GCS brings its clients unparalleled visibility, recognition and brand awareness. GCS is where news, content and information converge.

To receive SMS text alerts from Green Car Stocks, text “Green” to 21000 (U.S. Mobile Phones Only)

For more information, please visit https://www.GreenCarStocks.com

Please see full terms of use and disclaimers on the Green Car Stocks website applicable to all content provided by GCS, wherever published or re-published: https://www.GreenCarStocks.com/Disclaimer

Green Car Stocks
San Francisco, California
www.GreenCarStocks.com
415.949.5050 Office
Editor@GreenCarStocks.com

Green Car Stocks is part of the InvestorBrandNetwork.

Thursday, September 2nd, 2021 Uncategorized Comments Off on $NETE EV Firms Opt for More Affordable Production Methods

$INM Cannabis Industry Investor Conference: Company Executives Present September 8th & 9th

Cannabis Industry Investor Conference: Company Executives Present September 8th & 9th

Cannabis Company Executives share vision, answer questions live at VirtualInvestorConferences.com

PR Newswire

NEW YORK Sept. 2, 2021 /PRNewswire/ — Virtual Investor Conferences in partnership with KCSA Strategic Communications today announced the agenda for the upcoming Cannabis Industry Virtual lnvestor Conference. Individual investors, institutional investors, advisors and analysts are invited to attend. The two-day program begins at 11:30 AM ET on Wednesday , September 8 th .

(PRNewsfoto/VirtualInvestorConferences.com)

REGISTER NOW AT: https://bit.ly/2WFxX0e

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There are no fees to log-in, attend the live presentations or ask questions.

Phil Carlson , Managing Director of KCSA Strategic Communications said, “Our 15 th virtual conference with the OTC Markets has generated significant interest from both investors and cannabis companies to where we again have extended the conference to two days. We look forward to having some of the prominent global players in the cannabis industry present their story to the investment community.”

September 8 th Agenda:

Eastern
Time (ET)

Presenting Company

Ticker(s)

11:30 AM

Innocan Pharma Corp.

OTCQX: INNPF | CSE: INNO)

12:00 PM

MariMed Inc.

OTCQX: MRMD )

12:30 PM

The Valens Company Inc.

OTCQX: VLNCF | TSX: VLNS)

1:00 PM

Nova Cannabis Inc.

OTCQB: NVACF | TSX-V: NOVC)

1:30 PM

InMed Pharmaceuticals Inc.

Nasdaq: INM )

2:00 PM

Vibe Growth Corp.

Pink: VIBEF | CSE: VIBE)

2:30 PM

1933 Industries Inc.

OTCQB: TGIFF | CSE: TGIF

September 9 th Agenda:

Eastern
Time (ET)

Presenting Company

Ticker(s)

10:00 AM

IM Cannabis Corp.

NASDAQ: IMCC | CSE: IMCC)

10:30 AM

NewLake Capital Partners, Inc.

OTCQX: NLCP )

11:00 AM

Aleafia Health Inc.

OTCQX: ALEAF | TSX: AH)

11:30 AM

InterCure Ltd.

NASDAQ: INCR | TSX: INCR.U)

12:00 PM

Verano Holdings Corp.

OTCQX: VRNOF | CSE: VRNO)

12:30 PM

Fire & Flower Holdings Corp.

OTCQX: FFLWF | TSX: FAF)

1:00 PM

SLANG Worldwide Inc.

OTCQB: SLGWF | CSE: SLNG)

1:30 PM

Clever Leaves Holdings Inc.

(N ASDAQ: CLVR , CLVRW)

2:00 PM

Australis Capital Inc.

OTCQB: AUSAF | CSE: AUSA)

2:30 PM

Lowell Farms Inc.

OTCQX: LOWLF | CSE: LOWL)

3:00 PM

Flower One Holdings Inc.

OTCQX: FLOOF | CSE: FONE)

3:30 PM

Sugarbud Craft Growers Corp.

OTCQB: SBUDF | TSX-V: SUGR)

4:00 PM

Greenrose Acquisition Corp.

OTCQX: GNRS , GNRSU, GNRSW)

To facilitate investor relations scheduling, for more information about the program and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com .

About Virtual Investor Conferences SM
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly-traded companies to meet and present directly with investors.

A real-time solution for investor engagement, Virtual Investor Conferences is part of OTC Market Group’s suite of investor relations services specifically designed for more efficient Investor Access.  Replicating the look and feel of on-site investor conferences, Virtual Investor Conferences combine leading-edge conferencing and investor communications capabilities with a comprehensive global investor audience network.

Thursday, September 2nd, 2021 Uncategorized Comments Off on $INM Cannabis Industry Investor Conference: Company Executives Present September 8th & 9th

$CYBN Grand Rapids One Step Closer to Decriminalizing Entheogenic Plants, Fungi

The city of Grand Rapids, Michigan, may soon deprioritize the enforcement of laws against the use, growing and possession of entheogenic fungi and plants. Grand Rapids city commissioner Kurt Reppart stated that, while this wouldn’t decriminalize the psychedelics, it would allow individuals to gift, grow, use or possess psychedelics without facing any legal charges.

Reppart is in favor of making psychedelics the lowest priority for the city’s law enforcement and believes that the move will not only acknowledge that these fungi and plants can not only be medicines for individuals using them to treat conditions such as anxiety, depression, addiction and PTSD, but that they also save resources.

The move also brings the city one step closer to decriminalization, which is what Decriminalize Nature Grand Rapids, a chapter of the national group that calls for the decriminalization and destigmatization of entheogenic fungi and plants across the country, is working towards. The chapter’s founder and board member Chad Beyer stated that decriminalization was risk reduction given that many people in the city as well as the country were already using these drugs.

The city of Grand Rapids has one of the highest depression rates in the United States. Decriminalize Nature Grand Rapids believes that decriminalization would allow affected individuals who would like to try this alternative to do so.

Some believe that psychedelics are a much better option than current options, given that opioids and antidepressants are not only expensive but also ineffective in some individuals. Opioids are also highly addictive, which makes them dangerous. Beyer, who was diagnosed with an incurable neurological disease known as spinocerebellar ataxia five years ago, revealed that he’d used psilocybin mushrooms as part of his treatment in the past.

The growing interest in psychedelics as well as the destigmatization of mental health also encourages academia to study these substances. The U.S. FDA, the University of California-Berkeley, Johns Hopkins and Yale are some of the many institutions that have conducted studies on entheogenic fungi and plants in a bid to discover their medical benefits.

This isn’t the first city in the state of Michigan to consider psychedelic measures. Last year in September, the city of Ann Arbor decriminalized the cultivation, use and possession of entheogenic plants and fungi. Soon after, Washtenaw County Prosecutor Eli Savit announced that he would not prosecute any cases of cultivation, use or possession of entheogenic plants and fungi, which made these cases a low priority for law enforcement.

The growing wave to decriminalize various psychedelic compounds is coming at a time when a number of companies, including Cybin Inc. (NEO: CYBN) (NYSE American: CYBN), have made progress in developing therapeutic formulations from substances such as psilocybin, or magic, mushrooms and other psychedelics.

NOTE TO INVESTORS: The latest news and updates relating to Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) are available in the company’s newsroom at https://ibn.fm/CYBN

About PsychedelicNewsWire

PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.

To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.PsychedelicNewsWire.com

Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer

Do you have questions or are you interested in working with PNW? Ask our Editor

PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
Editor@PsychedelicWire.com

PsychedelicNewsWire is part of the InvestorBrandNetwork.

Thursday, September 2nd, 2021 Uncategorized Comments Off on $CYBN Grand Rapids One Step Closer to Decriminalizing Entheogenic Plants, Fungi

$BRSF Expanded Vision for Neurology Telemedicine Combines Diagnostic Solutions, AI, ML, and Cloud-Based Infrastructure

Brain Scientific (OTCQB: BRSF), a commercial-stage medical device and software company focused on neurology, has developed cost-effective and portable proprietary brain diagnostic solutions — the NeuroCap(TM) and NeuroEEG(TM) — that are positioned to disrupt the electroencephalogram (“EEG”) market. With nearly every U.S. state experiencing a neurologist shortfall and experts warning that access to high-level care and diagnosis is immediately required to reduce mental disability, improve patient outcomes and increase the wellbeing of the current pool of neurologists, Brain Scientific aims to support the industry through its diagnostic solutions. A recent article explains: “These portable devices are part of the company’s expanded vision for neurology telemedicine, allowing practitioners to collect diagnostic information quickly, upload it to cloud-based infrastructure, and leverage artificial intelligence (‘AI’) and machine learning (‘ML’) algorithms to detect seizures, dementia and other brain-related conditions.”

To view the full article, visit: https://ibn.fm/44KaU

About Brain Scientific Inc.

Brain Scientific is a commercial-stage health-care company with two FDA-cleared products, providing next-gen solutions to the neurology market. The company’s smart diagnostic devices and sensors simplify administration, shorten scan time and cut costs, allowing clinicians to make rapid decisions remotely and bridge the widening gap in access to neurological care. To learn more about the company’s corporate strategy, devices or for investor relations, visit www.BrainScientific.com.

NOTE TO INVESTORS: The latest news and updates relating to BRSF are available in the company’s newsroom at http://ibn.fm/BRSF

About BioMedWire

BioMedWire (BMW) is a bio-med news and content distribution company that provides (1) access to a network of wire services via NetworkWire to reach all target markets, industries and demographics in the most effective manner possible, (2) article and editorial syndication to 5,000+ news outlets (3), enhanced press release services to ensure maximum impact, (4) social media distribution via the Investor Brand Network (IBN) to nearly 2 million followers, (5) a full array of corporate communications solutions, and (6) a total news coverage solution with BMW Prime. As a multifaceted organization with an extensive team of contributing journalists and writers, BMW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, BMW brings its clients unparalleled visibility, recognition and brand awareness. BMW is where news, content and information converge.

To receive SMS text alerts from BioMedWire, text “STOCKS” to 77948 (U.S. Mobile Phones Only)

For more information, please visit https://www.BioMedWire.com

Please see full terms of use and disclaimers on the BioMedWire website applicable to all content provided by BMW, wherever published or re-published: http://BMW.fm/Disclaimer

BioMedWire (BMW)
San Francisco, California
www.BioMedWire.com
415.949.5050 Office
Editor@BioMedWire.com

BioMedWire is part of the InvestorBrandNetwork.

Thursday, September 2nd, 2021 Uncategorized Comments Off on $BRSF Expanded Vision for Neurology Telemedicine Combines Diagnostic Solutions, AI, ML, and Cloud-Based Infrastructure

$AMPG Well Positioned to Actively Pursue Emerging Revenue Opportunities, Growth Plans

AmpliTech Group (NASDAQ: AMPG) recently reported it had secured a follow-on order for its low noise amplifier (“LNA”) technology from a long-standing Fortune 500 global defense and aerospace customer. According to Fawad Maqbool, AMPG’s founder and CEO, the order demonstrated that the performance, quality and return on investment of the company’s solutions were continuing to earn repeat businesses from global leaders. “Maqbool also noted that as the economy reopens, the company’s target customers and industries are returning to more normal business and procurement patterns, creating an expanding range of revenue opportunities. Also, with its existing resources, including about $30 million in net cash raised following a recapitalization over the first four months of 2021, the company is well positioned to actively pursue aggressive growth plans and opportunities,” reads a recent article. AMPG was also recently added to the Russell Microcap Index. Maqbool commented: “We expect AmpliTech’s exciting outlook to be supported by the added investment community visibility and awareness provided by our Russell Index Inclusion.”

To view the full article, visit https://ibn.fm/XXEwr

About AmpliTech Group Inc.

AmpliTech Group designs, develops and manufactures state-of-the-art radio frequency (“RF”) components for global satellite communications, telecom (5G & IoT), space, defense, and quantum computing markets as well as provides systems and component design consulting services. AmpliTech has a 13+ year track record of developing high performance, custom solutions to meet the unique needs of some of the largest companies in the global industries it serves. The company is proud of the unique skills, experience and dedication of its focused team, which enables AmpliTech to deliver superior solutions, faster time to market, competitive pricing and excellent customer satisfaction and repeat business. For more information about the company, visit www.AmpliTechinc.com.

NOTE TO INVESTORS: The latest news and updates relating to AMPG are available in the company’s newsroom at http://ibn.fm/AMPG

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Thursday, September 2nd, 2021 Uncategorized Comments Off on $AMPG Well Positioned to Actively Pursue Emerging Revenue Opportunities, Growth Plans

$WTER Alkaline88(R) Coming Soon to 9 Major US Airports

The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company and The Clean Beverage Company(TM), today announced that its one-liter and 700ml bottles of Alkaline88(R) will be available in over 100 retail locations in nine major U.S. airports. “With the rebounding of the airline industry, this was an ideal time for Alkaline88 to enter into this channel. The sales team and our new director of hospitality and foodservice, Gary Bliss, have done an amazing job securing this deal. Now, hundreds of millions of passengers will have access to Deliciously Smooth(TM) Alkaline88 as they travel through major airports to destinations around the world. Featured in over 100 retail locations, our brand will be accessible to every passenger that enters these terminals,” said Ricky Wright, president and CEO of The Alkaline Water Company. “These airports represent nine of the top 30 airports in North America. They include the big three in New York City area—JFK, LaGuardia and Newark— Chicago O’Hare, Reagan National, Orlando International, George Bush Intercontinental/Houston, Minneapolis-St. Paul International, and Philadelphia International. In 2019, over 400 million passengers flew out of these airports.”

To view the full press release, visit https://ibn.fm/r6GPD

About The Alkaline Water Company Inc.

Founded in 2012, The Alkaline Water Company is headquartered in Scottsdale, Arizona. Its flagship product, Alkaline88(R), is a leading premier alkaline water brand available in bulk and single-serve sizes along with eco-friendly aluminum packaging options. With its innovative, state-of-the-art proprietary electrolysis process, Alkaline88 delivers perfect 8.8 pH-balanced alkaline drinking water with trace minerals and electrolytes and boasts its trademarked label: Clean Beverage. Quickly being recognized as a growing lifestyle brand, Alkaline88 launched A88 Infused(TM) in 2019 to meet consumer demand for flavor-infused products. A88 Infused flavored water is available in six unique, all-natural flavors with new flavors coming soon. In 2021, The Alkaline Water Company was pleased to welcome Shaquille O’Neal to its board of advisors and to serve as the celebrity brand ambassador for the Alklaine88 and A88 Infused brands. To purchase Alkaline88 and A88 Flavor Infused products online, visit www.Alkaline88.com. To learn more about the company, visit www.TheAlkalineWaterCo.com.

NOTE TO INVESTORS: The latest news and updates relating to WTER are available in the company’s newsroom at http://ibn.fm/WTER

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, September 1st, 2021 Uncategorized Comments Off on $WTER Alkaline88(R) Coming Soon to 9 Major US Airports

$PLTXF Launches Redesigned Canadian Website on Shopify

PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced the launch of its redesigned Canadian website www.PlantX.ca, powered by Shopify. The new website features a refreshed and modern design, simplified navigation and upgraded search tools and functionality to enhance overall user experience and brand impact. “The decision to transition to Shopify as the main e-commerce platform to host the PlantX online presence is a strategic move that complements the company’s mission and expansion plans,” said PlantX Founder Sean Dollinger. “By leveraging the Shopify embedded features, PlantX will be able to replicate its current Canadian model and launch additional websites in other countries.”

To view the full press release, visit https://ibn.fm/0p6e3

About PlantX Life Inc.

As the digital face of the plant-based community, PlantX’s platform is the one-stop shop for everything plant-based. With its fast-growing category verticals, the company offers customers across North America more than 10,000 plant-based products. In addition to offering meal and indoor plant deliveries, the company currently has plans underway to expand its product lines to include cosmetics, clothing and its own water brand — but the business is not limited to an e-commerce platform. The company uses its digital platform to build a community of like-minded consumers and, most importantly, provide education. Its successful enterprise is being built and fortified on partnerships with top nutritionists, chefs and brands. The company eliminates the barriers to entry for anyone interested in living a plant-based lifestyle and thriving in a longer, healthier and happier life. For more information, visit the company’s investor website at https://Investor.PlantX.com and visit PlantX’s YouTube channel.

NOTE TO INVESTORS: The latest news and updates relating to PLTXF are available in the company’s newsroom at http://ibn.fm/PLTXF

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, September 1st, 2021 Uncategorized Comments Off on $PLTXF Launches Redesigned Canadian Website on Shopify

$LEXX Targets Burgeoning Hypertension, Antiviral Therapeutics Markets with Drug Delivery Technology

  • Lexaria has progressed significantly in evidencing that its patented DehydraTECH(TM) drug delivery technology can sufficiently improve the usable fraction of known antiviral drugs that reach the bloodstream
  • According to a Newsfile Corp. article, this technology can be applied to rendering treatments for HIV/AIDS and other infectious diseases more effective
  • The company also released partial results from a human clinical study evaluating DehydraTECH-processed CBD for potential application against hypertension, which evidenced a rapid and sustained drop in blood pressure
  • Growing hypertension and antiviral therapeutics market represent a potential win for Lexaria

In July, Lexaria Bioscience (NASDAQ: LEXX), a drug delivery technology developer, issued several key announcements that, in addition to highlighting the progress made in advancing its patented DehydraTECH(TM) drug delivery technology, form the basis of analysis in a recent Newsfile Corp. article (https://cnw.fm/gr5fu).

On July 22, the Kelowna-based global innovator reviewed its successful 2021 antiviral drug program. With diseases caused by viruses, including HIV/AIDS, influenza, and, more recently, COVID-19, having made the demand and need for effective antiviral drugs via oral delivery that are available to all more profound than ever before, Lexaria has made strides. The company has progressed significantly in evidencing that DehydraTECH can sufficiently enhance the usable fraction of known antiviral drugs that reach the bloodstream to safely and more effectively do what they are designed to accomplish. Still, it continues to evaluate the data generated from the program (https://cnw.fm/bUyjG).

According to the Newsfile article, the antivirals represent a much broader market for DehydraTECH, especially currently, because in response to COVID-19, they “are having a moment.” Even so, “the same technology can be applied to rendering treatments for AIDS and other infectious diseases more effective. Antihistamines and anti-inflammatory drugs, as well as such therapeutics as remdesivir, have all been shown to be enhanced by DehydraTECH in animal studies,” the article notes.

Lexaria is likely to benefit from the projected growth in the global antiviral therapeutics market, which is expected to surge to $67.76 billion in 2026 from $51.26 billion in 2020, representing a 4.76% CAGR. Analysts at Mordor Intelligence peg this growth on robust R&D investment in antiviral drugs by public and private companies (https://cnw.fm/Uo7Da).

Notably, the antiviral program is just one of several others Lexaria is focusing on at present. Another applied R&D program, which also featured prominently in the Newsfile article, is hypertension. On July 29, the company released partial results from a human clinical study, HYPER-H21-1, evaluating DehydraTECH-processed cannabidiol (“CBD”) for potential application against hypertension (https://cnw.fm/rYTu4).

The study revealed a rapid and sustained drop in blood pressure with DehydraTECH-processed CBD and was most pronounced within the first 10 to 50 minutes of the study. This evidence reinforced the company’s pre-existing findings and further demonstrated that its drug delivery technology offers superior performance over generic CBD controls (https://cnw.fm/siHme).

“That CBD would be among the first use cases for such a platform as DehydraTECH makes sense,” reads the Newsfile article, “FDA-approved for pediatric seizure purposes since 2018, it has gained a great deal of traction over a short period of time. While its most closely identified delivery vector is hemp cigarettes, these can damage lungs as much as pills can damage livers.”

The article further notes that hypertension represents a new market for CBD and a potential huge win for Lexaria. Valued at $27.8 billion in 2018, the antihypertensive drug market is expected to grow at a CAGR of about 2% from 2019 to 2027 (https://cnw.fm/eGUpU).

On July 28, Lexaria announced that DehydraTECH is available for sale in more than 7,000 stores across the US, in what CEO Chris Bunka noted was an indication that the delivery technology is enabling increased market share and sales growth for its expanding list of corporate clients (https://cnw.fm/RZw9S).

The article also highlights Lexaria’s financial information. “Its balance sheet is clean, but that is in large part due to Lexaria’s ability to raise money on financial markets. Earnings are not what one would hope for, and yet the market cap is roughly 10x assets, suggesting high confidence in management,” it concludes.

For more information, visit the company’s website at www.LexariaBioscience.com.

NOTE TO INVESTORS: The latest news and updates relating to LEXX are available in the company’s newsroom at https://cnw.fm/LEXX

About CBDWire

CBDWire (CBDW) is a specialized information provider focused on (1) reporting CBD-related news and updates, (2) releasing CBDNewsBreaks crafted to keep investors abreast of the latest and greatest in the CBD market, (3) refining and enhancing corporate press releases, (4) delivering end-to-end distribution and social media services to client-partners and (5) constructing effective corporate communication solutions based on the unique requirements of CBD companies. CBDW is exclusively positioned in the burgeoning CBD sector with a proven team of journalists and researchers working to deliver high quality content to an expansive target audience of investors, consumers and industry news outlets. Our dissemination network of over 5,000 downstream distribution points allows us to deliver unparalleled reach, visibility and recognition to companies operating in both cannabidiol and the wider cannabis space. CBDWire (CBDW) is where CBD news, content and information converge.

To receive instant SMS alerts, text CBDWire to 21000 (U.S. Mobile Phones Only)

For more information please visit https://www.CBDWire.com

Please see full terms of use and disclaimers on the CBDWire website applicable to all content provided by CBDW, wherever published or re-published: https://CBDWire.com/Disclaimer

Do you have questions or are you interested in working with CNW? Ask Our Editor

CBDWire (CBDW)
Denver, Colorado
www.CBDWire.com
303.498.7722 Office
Editor@CBDWire.com

CBDWire is part of the InvestorBrandNetwork.

Wednesday, September 1st, 2021 Uncategorized Comments Off on $LEXX Targets Burgeoning Hypertension, Antiviral Therapeutics Markets with Drug Delivery Technology

$KAVL Eyes Launch of New Proprietary CBD Products

Kaival Brands (NASDAQ: KAVL), a company focused on developing products into mature, dominant brands, is looking to launch a new line of proprietary cannabidiol (“CBD”) products. The company intends to follow a similar design path set by its highly successful Bidi(R) Stick product, the number one electronic nicotine delivery systems (“ENDS”) offering in the U.S. market, while using the same first-in-class, patented delivery mechanism that gives its consumer base a unique and premium vaping experience. “Along with providing users with a convenient, smoke-free delivery method for CBD, KAVL’s industrial-grade hemp formula promises greater bio-availability than many market competitors, resulting in less product used and overall superior consumer experience,” reads a recent article. According to Niraj “Raj” Patel, Kaival Brands founder and CEO, the company’s mission “is to set new industry standards by providing the highest quality and most effective products in the hemp CBD marketplace.”

To view the full article, visit https://ibn.fm/Z7Q7k

About About Kaival Brands Innovations Group Inc.

Based in Grant, Florida, Kaival Brands is a company focused on growing and incubating innovative and profitable products into mature and dominant brands in their respective markets. The company’s vision is to develop internally, acquire, own, or exclusively distribute these innovative products and grow each into dominant market-share brands with superior quality and recognizable innovation. Kaival Brands is the exclusive global distributor of all products currently manufactured by Bidi(R) Vapor LLC, a leader in disposable electronic nicotine delivery systems (“ENDS”), and is poised to expand internationally. For more information about the company, visit www.KaivalBrands.com.

NOTE TO INVESTORS: The latest news and updates relating to KAVL are available in the company’s newsroom at http://ibn.fm/KAVL

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.InvestorWire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.InvestorWire.com
Editor@NetworkNewsWire.com

InvestorWire is part of the InvestorBrandNetwork.

Wednesday, September 1st, 2021 Uncategorized Comments Off on $KAVL Eyes Launch of New Proprietary CBD Products

$IDEX Biometrics: Employee Share Purchase Plan Share Issue – 1 September 2021

The board of directors of IDEX Biometrics ASA has resolved to issue 913,198 ordinary shares at NOK 2.10 per share to employees who participate in the company’s 2020 Employee Share Purchase Plan (2020 ESPP), which plan was approved by the annual general meeting on 15 May 2020.

53 employees participated in the 2020 ESPP in this cycle. The participating employees have elected to invest a part of the base salary in ordinary shares in the company. Purchase takes place every three months. The shares are restricted for three months.

Following the issue, the Company’s share capital will be NOK 137,926,078.20 divided into 919,507,188 shares each with a nominal value of NOK 0.15.

Primary insiders
IDEX discloses transactions by the following primary insiders in IDEX shares ISIN NO0003070609:
–   CEO Vince Graziani acquired 20,490 ordinary shares at NOK 2.10 per share.
–   CTO Anthony Eaton acquired 8,029 ordinary shares at NOK 2.10 per share.

IDEX 2020 ESPP
The 2020 ESPP was approved at the annual general meeting on 15 May 2020. Reference is made to the notice of said meeting where the plan document in connection with the 2020 ESPP is attached.

All employees in the Company and its subsidiaries, except in China, have been offered to subscribe for shares in the Company in connection with the ESPP. The 2020 ESPP is structured around four contribution periods a year, each starting on the first day of the calendar month following each planned disclosure of an interim report of the Company and lasts for the following three months. During each contribution period, a fixed amount (up to 20% of the employee’s gross base salary) is withheld from the employee’s net salary. The employee may sign up to participate in the ESPP from the date of a public disclosure of an interim report until the beginning of the contribution period. Unless the employee actively withdraws from the ESPP, participation is automatically renewed for the same amount for subsequent contribution periods. The board’s resolution to issue new shares in connection with the ESPP is made pursuant to the authorization granted by the Company’s annual general meeting on 15 May 2020 to increase the Company’s share capital in connection with the ESPP. The 2020 ESPP is now closed for further contributions and purchases.

In accordance with the ESPP, the subscription price is the lower closing price of the Company’s share, as traded on Oslo Børs, on the first or last day of the contribution period, less 15% discount. Payment of the subscription amount is made out of the relevant employee salary withholding.

In accordance with Regulation (EU) 2017/1129 (the “Prospectus Regulation”) Article 1 (5) h, issuance of shares in connection with the ESPP is exempt from the obligation to publish a listing prospectus.

For further information contact:
Marianne Bøe, Investor Relations
E-mail: marianne.boe@idexbiometrics.com
Tel: + 47 918 00186

About IDEX Biometrics
IDEX Biometrics ASA (OSE: IDEX and Nasdaq: IDBA) is a leading provider of fingerprint identification technologies offering simple, secure, and personal touch-free authentication for all. We help people make payments, prove their identity, gain access to information, unlock devices, or gain admittance to buildings. We invent, engineer, and commercialize these secure and safe yet incredibly user-friendly solutions. Our total addressable market represents a fast growing multi-billion-unit opportunity.

Wednesday, September 1st, 2021 Uncategorized Comments Off on $IDEX Biometrics: Employee Share Purchase Plan Share Issue – 1 September 2021